These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 8382111)
1. Aberrations of p53 gene in human hepatocellular carcinoma from China. Li D; Cao Y; He L; Wang NJ; Gu JR Carcinogenesis; 1993 Feb; 14(2):169-73. PubMed ID: 8382111 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies. Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911 [TBL] [Abstract][Full Text] [Related]
3. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. Hsu IC; Tokiwa T; Bennett W; Metcalf RA; Welsh JA; Sun T; Harris CC Carcinogenesis; 1993 May; 14(5):987-92. PubMed ID: 8389256 [TBL] [Abstract][Full Text] [Related]
4. Aflatoxin and p53 abnormality in duck hepatocellular carcinoma. Imazeki F; Yokosuka O; Ohto M; Omata M J Gastroenterol Hepatol; 1995; 10(6):646-9. PubMed ID: 8580407 [TBL] [Abstract][Full Text] [Related]
5. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Fujimoto Y; Hampton LL; Wirth PJ; Wang NJ; Xie JP; Thorgeirsson SS Cancer Res; 1994 Jan; 54(1):281-5. PubMed ID: 7903205 [TBL] [Abstract][Full Text] [Related]
6. P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India. Katiyar S; Dash BC; Thakur V; Guptan RC; Sarin SK; Das BC Cancer; 2000 Apr; 88(7):1565-73. PubMed ID: 10738214 [TBL] [Abstract][Full Text] [Related]
7. The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non HCC prevalent area in China. Liu H; Wang Y; Zhou Q; Gui SY; Li X World J Gastroenterol; 2002 Jun; 8(3):480-2. PubMed ID: 12046074 [TBL] [Abstract][Full Text] [Related]
8. Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxin B1. Park US; Su JJ; Ban KC; Qin L; Lee EH; Lee YI Gene; 2000 Jun; 251(1):73-80. PubMed ID: 10863098 [TBL] [Abstract][Full Text] [Related]
9. Tumour suppressor p53 and Rb genes in human hepatocellular carcinoma. Lin Y; Shi CY; Li B; Soo BH; Mohammed-Ali S; Wee A; Oon CJ; Mack PO; Chan SH Ann Acad Med Singap; 1996 Jan; 25(1):22-30. PubMed ID: 8779541 [TBL] [Abstract][Full Text] [Related]
10. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015 [TBL] [Abstract][Full Text] [Related]
11. An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico. Soini Y; Chia SC; Bennett WP; Groopman JD; Wang JS; DeBenedetti VM; Cawley H; Welsh JA; Hansen C; Bergasa NV; Jones EA; DiBisceglie AM; Trivers GE; Sandoval CA; Calderon IE; Munoz Espinosa LE; Harris CC Carcinogenesis; 1996 May; 17(5):1007-12. PubMed ID: 8640905 [TBL] [Abstract][Full Text] [Related]
12. State of the p53 gene in hepatocellular carcinomas of ground squirrels and woodchucks with past and ongoing infection with hepadnaviruses. Rivkina MB; Cullen JM; Robinson WS; Marion PL Cancer Res; 1994 Oct; 54(20):5430-7. PubMed ID: 7923176 [TBL] [Abstract][Full Text] [Related]
13. Different frequencies of p53 codon-249 hot-spot mutations in hepatocellular carcinomas in Jiang-su province of China. Shimizu Y; Zhu JJ; Han F; Ishikawa T; Oda H Int J Cancer; 1999 Jul; 82(2):187-90. PubMed ID: 10389750 [TBL] [Abstract][Full Text] [Related]
14. [p53 gene mutation in hepatocellular carcinoma]. Jiang W; Lu Q; Pan G Zhonghua Wai Ke Za Zhi; 1998 Sep; 36(9):531-2. PubMed ID: 11825456 [TBL] [Abstract][Full Text] [Related]
15. Geographic variation of p53 mutational profile in nonmalignant human liver. Aguilar F; Harris CC; Sun T; Hollstein M; Cerutti P Science; 1994 May; 264(5163):1317-9. PubMed ID: 8191284 [TBL] [Abstract][Full Text] [Related]
16. Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis. Shen HM; Ong CN Mutat Res; 1996 Oct; 366(1):23-44. PubMed ID: 8921985 [TBL] [Abstract][Full Text] [Related]
17. Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations. Rashid A; Wang JS; Qian GS; Lu BX; Hamilton SR; Groopman JD Br J Cancer; 1999 Apr; 80(1-2):59-66. PubMed ID: 10389978 [TBL] [Abstract][Full Text] [Related]
18. Genomic aberrations in human hepatocellular carcinomas of differing etiologies. Wong N; Lai P; Pang E; Fung LF; Sheng Z; Wong V; Wang W; Hayashi Y; Perlman E; Yuna S; Lau JW; Johnson PJ Clin Cancer Res; 2000 Oct; 6(10):4000-9. PubMed ID: 11051249 [TBL] [Abstract][Full Text] [Related]
19. Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas. Hosono S; Chou MJ; Lee CS; Shih C Oncogene; 1993 Feb; 8(2):491-6. PubMed ID: 8093978 [TBL] [Abstract][Full Text] [Related]
20. Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma. Shieh YS; Nguyen C; Vocal MV; Chu HW Int J Cancer; 1993 Jun; 54(4):558-62. PubMed ID: 8390407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]